Terna Green Tf 3,875% Lg33 Call Eur (995135) News

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular...

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum PR Newswire PHILADELPHIA, June 25...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders PR Newswire PHILADELPHIA, June...

CARMILA: Information Concerning the Total Number of Voting Rights and Share

provided pursuant to article L.233-8 II of the Code de commerce (French Commercial Code) and article 223-16 of the Règlement général de...

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference PR Newswire PHILADELPHIA...

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights PR...